Pittsburgh-based biotech company, Krystal Biotech, recently announced FDA approval of a revolutionary and redosable gene therapy to treat dystrophic epidermolysis bullosa (DEB)
On the first day of XchangeInnovation Week, LifeX, Innovation Works and Nucleate Pittsburgh shared what their accelerators and networking groups can do.
Cofounders Brad Holden and Charlie Proctor hope their North Side-based startup's wearable device will be a crucial tool in addressing the opioid epidemic.